Abstract
The majority of reported cancer survival statistics in the United States are generated using the National Cancer Institute's publicly available Surveillance, Epidemiology, and End Results (SEER) data, which prior to 2019 represented 28% of the US population (now 37%). In the case of rare cancers or special subpopulations, data sets based on a larger portion of the US population may contribute new insights into these low-incidence cancers. The purpose of this study is to characterize the histology-specific survival patterns for all primary malignant and nonmalignant primary brain tumors in the United States using the Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR). Survival data were obtained from the NPCR (includes data from 39 state cancer registries, representing 81% of the US population). Relative survival rates (RS) with 95% CI were generated using SEER*Stat 8.3.5 from 2004 to 2014 by behavior, histology, sex, race/ethnicity, and age at diagnosis. Overall, there were 488 314 cases from 2004 to 2014. Overall 5-year RS was 69.8% (95% CI = 69.6%-69.9%). Five-year RS was 35.9% (95% CI = 35.6%-36.1%) for malignant and 90.2% (95% CI = 90.1%-90.4%) for nonmalignant tumors. Pilocytic astroc...Continue Reading
References
Dec 29, 2015·Statistics in Medicine·Karri SeppäJanne Pitkäniemi
May 10, 2016·Acta Neuropathologica·David N LouisDavid W Ellison
Jun 17, 2016·Journal of Neuro-oncology·James E BatesMichael T Milano
Feb 25, 2017·World Neurosurgery·Ha Son NguyenSaman Shabani
Aug 23, 2017·Journal of Neuro-oncology·Vishesh KhannaPeter M de Blank
Dec 6, 2017·Cancer·Claudia AllemaniMichel P Coleman
Feb 6, 2018·Lancet·Claudia AllemaniUNKNOWN CONCORD Working Group
Feb 9, 2018·Journal of Neuro-oncology·Tabitha CooneySonia Partap
Feb 24, 2018·Neuro-oncology·Quinn T OstromJill S Barnholtz-Sloan
May 23, 2018·Cancer·Kathleen A CroninAhmedin Jemal
Jun 22, 2018·PloS One·Andrew BohnNoël C Barengo
Jun 23, 2018·JAMA Oncology·Quinn T OstromJill S Barnholtz-Sloan
Nov 18, 2018·Neuro-oncology·Quinn T OstromJill S Barnholtz-Sloan
Jan 24, 2019·Journal of Neuro-oncology·Jacob J MandelJohn F de Groot
Apr 27, 2019·Journal of Neuro-oncology·Haley GittlemanJill S Barnholtz-Sloan
Nov 2, 2019·Neuro-oncology·Quinn T OstromJill S Barnholtz-Sloan